Chronic liver disease (CLD) including hepatitis C, liver cancer, and non-alcoholic fatty liver disease (NAFLD) remains a significant and growing global health burden. Despite advancements in care, gaps in knowledge and clinical practice continue to impact the delivery of evidence-based treatment, highlighting the need for targeted education. This conference will address these gaps by focusing on current advances in hepatitis C and liver cancer, as well as the rising impact of NAFLD. Through interactive sessions and case-based discussions, participants will strengthen their ability to deliver coordinated, multidisciplinary, patient-centered care and improve outcomes for patients with CLD.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 1111 Marcus Avenue, Suite 107
Pricing
20% of listed courses are free
1 of 5 courses listed here are free.
Collected from the provider’s public pages
- No reviews yet. Be the first to share yours.
- Conference / congress
- Credit · Up to 6.5 credits
- MOC · Up to 6.5 points
- Paid · fee on provider site
-
WhenOct 23, 2026
-
Medvarsity Technologies Private Limited Non-Alcoholic Fatty Liver Disease (NAFLD): Diagnosis and Treatment
-
Answers in CME Inc. (AiCME) From Screening to Specialized Care: Navigating Key Questions in AATD-Associated Liver Disease
-
Obesity Medicine Association Obesity Medicine 2026 – Obesity Management in People with Chronic Liver Diseases (Recorded)
